Medical Bionic Implant/Artificial Organs Market Players Analysis By Segmentations, Regional Analysis, Future Development by 2030
Ngày đăng: 30-08-2023 |
Ngày cập nhật: 30-08-2023
Market Overview
Bionic implants are known as artificially engineered devices. These devices are implanted into a human in order to replace a natural organ and to act as a substitute of the same. The global medical bionic implant/artificial organs market size is projected to reach USD 22.17 billion by 2030 at a CAGR of 7.90% over the assessment period between 2022 and 2030.
It is reported that the growing incidences of organ failure to have a positive effect on increasing the demand for replaceable or implantable organs. This is thereby pushing the growth of the overall bionic implant/artificial organs market. The growing aging population is another key factor driving the market demand for these implantable/artificial organs as organ failure is found to be more common in the older age bracket.
A vast number of factors are identified as the potential drivers of the market, such as technological advancements, rising incidences of accidents and injuries, improving regulatory framework, prevalence of organ failure, increasing government support in terms of initiatives and R&D expenditures, and growing prevalence of eye diseases.
However, the high cost associated with the devices, poor healthcare facilities in low and mid-level income nations, and lack of any skilled or proficient professionals can hamper the growth of the market during the forecast period.
Competitive Landscape
The global medical bionic implant artificial organs market players includes the following key players
Market Segmentation
The global medical bionic implant/artificial organs market segmentation is done on the basis of product, technology, fixation, and end-user.
By technology, the market divides into electronic bionics and mechanic bionics.
By fixation, the market is classified into externally worn and implantable.
By end-users, the market includes research and academic institutes, hospitals and clinics, and others.
By product, the market comprises orthopedic bionics, ear bionics, vision bionics, neural/brain bionics, heart bionics, and others.
Here, vision bionics is narrowed down into bionic and others.
Ear bionics is segmented into Bone Anchored Hearing Aid (BAHA) and cochlear implant.
Orthopedic bionics sub-segmented into bionic finger, bionic leg, bionic hand, electrical bone growth stimulators, and exoskeleton. Bionic leg breaks down into bionic feet and bionic knee. Electrical bone growth stimulator segment comprises non-invasive bone growth stimulators and invasive bone growth stimulators.
Heart Bionics segment is divided into total artificial heart, artificial heart valve, pacemaker, and ventricular assist device. The pacemaker segment includes external pacemaker and implantable cardiac pacemaker. Artificial heart valve narrows down into tissue heart valve and mechanical heart valve.
Neural/brain bionics is broken down into vagus nerve stimulators, spinal cord stimulators, and deep brain stimulators.
Regional Analysis
The global medical bionic implant/artificial organs market insights is regionally segmented into North America, Europe, Asia Pacific, and the Middle East & Africa region.
The Americas hold the dominant portion of the market due to the emergence of advanced medical bionic implants by various key players.
Europe stands tall as the second largest market in medical bionic implant artificial organs. Herein, favorable government support towards research and development activities and prevalence of organ failure and other relevant complications are expected to be the major drivers of the market.
Asia Pacific is believed to be the fastest growing regional market due to the huge pool of patient population, increasing development in the healthcare technology, and growing demand for advanced form of treatments.
Finally, the Middle East and Africa market holds the lowest share in the global standings due to lack of technical expertise or knowledge, low level of development, and poor medical facilities. The region is expected to grow at a paltry rate.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
Bionic implants are known as artificially engineered devices. These devices are implanted into a human in order to replace a natural organ and to act as a substitute of the same. The global medical bionic implant/artificial organs market size is projected to reach USD 22.17 billion by 2030 at a CAGR of 7.90% over the assessment period between 2022 and 2030.
It is reported that the growing incidences of organ failure to have a positive effect on increasing the demand for replaceable or implantable organs. This is thereby pushing the growth of the overall bionic implant/artificial organs market. The growing aging population is another key factor driving the market demand for these implantable/artificial organs as organ failure is found to be more common in the older age bracket.
A vast number of factors are identified as the potential drivers of the market, such as technological advancements, rising incidences of accidents and injuries, improving regulatory framework, prevalence of organ failure, increasing government support in terms of initiatives and R&D expenditures, and growing prevalence of eye diseases.
However, the high cost associated with the devices, poor healthcare facilities in low and mid-level income nations, and lack of any skilled or proficient professionals can hamper the growth of the market during the forecast period.
Competitive Landscape
The global medical bionic implant artificial organs market players includes the following key players
- Biomet, Inc. (U.S.),
- NeuroPace, Inc. (U.S.),
- Medtronic, Inc. (U.S.),
- Aleva Neurotherapeutics SA (Switzerland),
- Boston Scientific Corporation (U.S.),
- Ekso Bionics (U.S.),
- Cochlear Ltd. (Australia),
- LivaNova PLC (U.K),
- Orthofix International N.V. (The Netherlands),
- Ossur (Iceland),
- Cyberonics, Inc. (U.S.),
- Biocontrol Medical (Israel),
- St. Jude Medical, Inc. (U.S.),
- Second Sight Medical Products, Inc. (U.S.), and others.
Market Segmentation
The global medical bionic implant/artificial organs market segmentation is done on the basis of product, technology, fixation, and end-user.
By technology, the market divides into electronic bionics and mechanic bionics.
By fixation, the market is classified into externally worn and implantable.
By end-users, the market includes research and academic institutes, hospitals and clinics, and others.
By product, the market comprises orthopedic bionics, ear bionics, vision bionics, neural/brain bionics, heart bionics, and others.
Here, vision bionics is narrowed down into bionic and others.
Ear bionics is segmented into Bone Anchored Hearing Aid (BAHA) and cochlear implant.
Orthopedic bionics sub-segmented into bionic finger, bionic leg, bionic hand, electrical bone growth stimulators, and exoskeleton. Bionic leg breaks down into bionic feet and bionic knee. Electrical bone growth stimulator segment comprises non-invasive bone growth stimulators and invasive bone growth stimulators.
Heart Bionics segment is divided into total artificial heart, artificial heart valve, pacemaker, and ventricular assist device. The pacemaker segment includes external pacemaker and implantable cardiac pacemaker. Artificial heart valve narrows down into tissue heart valve and mechanical heart valve.
Neural/brain bionics is broken down into vagus nerve stimulators, spinal cord stimulators, and deep brain stimulators.
Regional Analysis
The global medical bionic implant/artificial organs market insights is regionally segmented into North America, Europe, Asia Pacific, and the Middle East & Africa region.
The Americas hold the dominant portion of the market due to the emergence of advanced medical bionic implants by various key players.
Europe stands tall as the second largest market in medical bionic implant artificial organs. Herein, favorable government support towards research and development activities and prevalence of organ failure and other relevant complications are expected to be the major drivers of the market.
Asia Pacific is believed to be the fastest growing regional market due to the huge pool of patient population, increasing development in the healthcare technology, and growing demand for advanced form of treatments.
Finally, the Middle East and Africa market holds the lowest share in the global standings due to lack of technical expertise or knowledge, low level of development, and poor medical facilities. The region is expected to grow at a paltry rate.
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013
United States of America
